92 related articles for article (PubMed ID: 27908240)
1. New Fluorescent Macrolide Derivatives for Studying Interactions of Antibiotics and Their Analogs with the Ribosomal Exit Tunnel.
Tereshchenkov AG; Shishkina AV; Karpenko VV; Chertkov VA; Konevega AL; Kasatsky PS; Bogdanov AA; Sumbatyan NV
Biochemistry (Mosc); 2016 Oct; 81(10):1163-1172. PubMed ID: 27908240
[TBL] [Abstract][Full Text] [Related]
2. Conjugates of amino acids and peptides with 5-o-mycaminosyltylonolide and their interaction with the ribosomal exit tunnel.
Shishkina A; Makarov G; Tereshchenkov A; Korshunova G; Sumbatyan N; Golovin A; Svetlov M; Bogdanov A
Bioconjug Chem; 2013 Nov; 24(11):1861-9. PubMed ID: 24090034
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence polarization method to characterize macrolide-ribosome interactions.
Yan K; Hunt E; Berge J; May E; Copeland RA; Gontarek RR
Antimicrob Agents Chemother; 2005 Aug; 49(8):3367-72. PubMed ID: 16048949
[TBL] [Abstract][Full Text] [Related]
4. Visualizing the 16-membered ring macrolides tildipirosin and tilmicosin bound to their ribosomal site.
Poehlsgaard J; Andersen NM; Warrass R; Douthwaite S
ACS Chem Biol; 2012 Aug; 7(8):1351-5. PubMed ID: 22563863
[TBL] [Abstract][Full Text] [Related]
5. Stepwise binding of tylosin and erythromycin to Escherichia coli ribosomes, characterized by kinetic and footprinting analysis.
Petropoulos AD; Kouvela EC; Dinos GP; Kalpaxis DL
J Biol Chem; 2008 Feb; 283(8):4756-65. PubMed ID: 18079110
[TBL] [Abstract][Full Text] [Related]
6. Interplay between the ribosomal tunnel, nascent chain, and macrolides influences drug inhibition.
Starosta AL; Karpenko VV; Shishkina AV; Mikolajka A; Sumbatyan NV; Schluenzen F; Korshunova GA; Bogdanov AA; Wilson DN
Chem Biol; 2010 May; 17(5):504-14. PubMed ID: 20534348
[TBL] [Abstract][Full Text] [Related]
7. Kinetic studies on the interaction between a ribosomal complex active in peptide bond formation and the macrolide antibiotics tylosin and erythromycin.
Dinos GP; Kalpaxis DL
Biochemistry; 2000 Sep; 39(38):11621-8. PubMed ID: 10995229
[TBL] [Abstract][Full Text] [Related]
8. Conjugates of Desmycosin with Fragments of Antimicrobial Peptide Oncocin: Synthesis, Antibacterial Activity, Interaction with Ribosome.
Khairullina ZZ; Makarov GI; Tereshchenkov AG; Buev VS; Lukianov DA; Polshakov VI; Tashlitsky VN; Osterman IA; Sumbatyan NV
Biochemistry (Mosc); 2022 Sep; 87(9):871-889. PubMed ID: 36180983
[TBL] [Abstract][Full Text] [Related]
9. Peptide derivatives of antibiotics tylosin and desmycosin, protein synthesis inhibitors.
Sumbatyan NV; Korshunova GA; Bogdanov AA
Biochemistry (Mosc); 2003 Oct; 68(10):1156-8. PubMed ID: 14616087
[TBL] [Abstract][Full Text] [Related]
10. [Amino acid and peptide derivatives of the tylosin family of macrolide antibiotics modified at the aldehyde group].
Sumbatian NV; Kuznetsova IV; Karpenko VV; Fedorova NV; Chertkov VA; Korshunova GA; Bogdanov AA
Bioorg Khim; 2010; 36(2):265-76. PubMed ID: 20531486
[TBL] [Abstract][Full Text] [Related]
11. Interaction of Chloramphenicol Tripeptide Analogs with Ribosomes.
Tereshchenkov AG; Shishkina AV; Tashlitsky VN; Korshunova GA; Bogdanov AA; Sumbatyan NV
Biochemistry (Mosc); 2016 Apr; 81(4):392-400. PubMed ID: 27293096
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin.
Poulsen SM; Kofoed C; Vester B
J Mol Biol; 2000 Dec; 304(3):471-81. PubMed ID: 11090288
[TBL] [Abstract][Full Text] [Related]
13. Structural Insight into Interaction between C20 Phenylalanyl Derivative of Tylosin and Ribosomal Tunnel.
Makarov GI; Sumbatyan NV; Bogdanov AA
Biochemistry (Mosc); 2017 Aug; 82(8):925-932. PubMed ID: 28941460
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of protein synthesis on the ribosome by tildipirosin compared with other veterinary macrolides.
Andersen NM; Poehlsgaard J; Warrass R; Douthwaite S
Antimicrob Agents Chemother; 2012 Nov; 56(11):6033-6. PubMed ID: 22926570
[TBL] [Abstract][Full Text] [Related]
15. On the mechanism of action of 9-O-arylalkyloxime derivatives of 6-O-mycaminosyltylonolide, a new class of 16-membered macrolide antibiotics.
Karahalios P; Kalpaxis DL; Fu H; Katz L; Wilson DN; Dinos GP
Mol Pharmacol; 2006 Oct; 70(4):1271-80. PubMed ID: 16873579
[TBL] [Abstract][Full Text] [Related]
16. The slow dissociation rate of K-1602 contributes to the enhanced inhibitory activity of this novel alkyl-aryl-bearing fluoroketolide.
Krokidis M; Bougas A; Stavropoulou M; Kalpaxis D; Dinos GP
J Enzyme Inhib Med Chem; 2016; 31(2):276-82. PubMed ID: 25807301
[TBL] [Abstract][Full Text] [Related]
17. Modeling Interactions of Erythromycin Derivatives with Ribosomes.
Shishkina AV; Makarova TM; Tereshchenkov AG; Makarov GI; Korshunova GA; Bogdanov AA
Biochemistry (Mosc); 2015 Nov; 80(11):1500-7. PubMed ID: 26615442
[TBL] [Abstract][Full Text] [Related]
18. Influence of Substitutions in the Binding Motif of Proline-Rich Antimicrobial Peptide ARV-1502 on 70S Ribosome Binding and Antimicrobial Activity.
Brakel A; Krizsan A; Itzenga R; Kraus CN; Otvos L; Hoffmann R
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328571
[TBL] [Abstract][Full Text] [Related]
19. Binding site of the bridged macrolides in the Escherichia coli ribosome.
Xiong L; Korkhin Y; Mankin AS
Antimicrob Agents Chemother; 2005 Jan; 49(1):281-8. PubMed ID: 15616307
[TBL] [Abstract][Full Text] [Related]
20. Time-resolved binding of azithromycin to Escherichia coli ribosomes.
Petropoulos AD; Kouvela EC; Starosta AL; Wilson DN; Dinos GP; Kalpaxis DL
J Mol Biol; 2009 Jan; 385(4):1179-92. PubMed ID: 19071138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
